Search Results - platforms+%3e+drug+delivery+%3e+other+polymers

17 Results Sort By:
Novel Vaginal Drug Delivery Device (UCLA Case No. 2020-444)
Summary: UCLA researchers in the Departments of Biomedical Engineering and Medicine have developed vaginal drug delivery devices for the administration of contraceptives and antibiotics. Background: Globally, 1.9 billion women of reproductive age (15-49 years) use contraceptives. An additional 190 million women would use phrophylactics/contraceptives...
Published: 5/29/2025   |   Inventor(s): Leena Nathan, Song Li, Tamara Grisales, Mohammad Mahdi Hasani Sadrabadi
Keywords(s):  
Category(s): Platforms > Drug Delivery, Platforms > Drug Delivery > Antibody Delivery Platforms, Platforms > Drug Delivery > Other Polymers
Injectable Biodegradable Polymeric Complex for Glucose-Responsive Insulin Delivery (UCLA Case No. 2021-116)
Summary: UCLA researchers in the department of Bioengineering have developed a biodegradable material that is capable of releasing insulin in the presence of excess glucose mimicking the insulin secretion properties of pancreatic B-cells as a treatment for Diabetes Mellitus.Background: Diabetes mellitus currently affects more than 463 million people...
Published: 2/14/2025   |   Inventor(s): Zhen Gu
Keywords(s):  
Category(s): Platforms > Drug Delivery > Other Polymers, Therapeutics > Inflammation And Inflammatory Diseases, Therapeutics > Metabolism And Endocrinology
2013-741 Bioengineered Thymic Aggregates for Implantation
Bioengineered Thymic Aggregates For ImplantationSUMMARYResearchers led by Gay Crooks from the Department of Pathology and Laboratory Medicine at UCLA have bioengineered a thymus implant to treat immune diseases.BACKGROUNDThe thymus plays an important role in the immune cells by producing specialized white blood cells called T cells. Thymus implantation...
Published: 2/14/2025   |   Inventor(s): Gay Crooks, Amelie Montel-Hagen, Brile Chung
Keywords(s): Autoimmune, Drug Delivery, Hematology, Inflammatory Diseases, Other Polymers, Therapeutics & Vaccines
Category(s): Platforms > Drug Delivery, Therapeutics > Autoimmune, Therapeutics > Hematology, Platforms > Drug Delivery > Other Polymers, Therapeutics > Immunology And Immunotherapy
Photocurable Poly(ethylene Glycol) as a Bioink for the Inkjet 3D Pharming of Hydrophobic Drugs
UC Case No. 2018-197SUMMARY: UCLA researchers in the Department of Bioengineering have developed a novel inkjet 3D pharming technique that is fast, customizable, and compatible with hydrophobic drugs. BACKGROUND: 3D pharming is an innovative technique that combines 3D printing and 2D material deposition to create personalized drug tablets that...
Published: 7/17/2025   |   Inventor(s): Benjamin Wu, Chase Linsley
Keywords(s): Drug Delivery, Other Polymers, PEG
Category(s): Platforms > Drug Delivery > Other Polymers, Platforms > Drug Delivery > PEG
2015-602 Update To Degradable Trehalose Glycopolymers
Summary UCLA researchers in the Department of Chemistry & Biochemistry have designed an improved version of trehalose-based glycopolymer as a degradable alternative to PEG for the purpose of stabilizing a protein during storage and transport. Background A UCLA team led by Professor Heather Maynard has developed a family of polymers that effectively...
Published: 7/17/2025   |   Inventor(s):  
Keywords(s):  
Category(s): Platforms > Drug Delivery > Other Polymers
Mixtures of Synthetic Copolypeptide Hydrogels (UCLA Case No. 2019-238)
UCLA researchers in the Department of Bioengineering have developed a novel polypeptide-based hydrogel mixture that offers a large degree of biocompatibility and biodegradability while also offering the ability to tune mechanical properties. Specifically, these compositions allow for high hydrogel stiffness at low polymer concentrations, while retaining...
Published: 7/17/2025   |   Inventor(s): Timothy Deming
Keywords(s): Chemical Manufacturing & Industrial/Bulk Chemicals, Drug Delivery, Other Polymers
Category(s): Platforms > Drug Delivery > Other Polymers, Chemical > Industrial & Bulk Chemicals
2019-468 PERIODONTAL MICROPATCH AND USES THEREOF
INTRODUCTION:UCLA researchers in the Departments of Bioengineering and Dentistry have developed a patch-based drug delivery system for dental applications.BACKGROUND:Periodontitis is a chronic inflammatory disease that affects tissues surrounding the teeth, and it is estimated that 50% of the U.S. population suffers from some type of periodontal disease....
Published: 7/17/2025   |   Inventor(s):  
Keywords(s): Dental, Drug Delivery, Inflammatory Diseases, Medical Devices and Materials, Other Polymers
Category(s): Platforms > Drug Delivery > Other Polymers
2015-798 NONCRUSHABLE PILL FORMULATIONS
SUMMARY: UCLA Researchers in the Department of Chemistry have developed a drug formulation for opioids capable of deterring drug abuse. BACKGROUND: It is estimated that more than 115 Americans a day, died to opioid overdose in 2016. The currently projected estimate is that this number will increase to over 150 Americans a day fatally overdosing on opioids....
Published: 7/3/2025   |   Inventor(s): Heather Maynard, Erhan Bat
Keywords(s): Drug Delivery, Nanoparticles, Other Polymers
Category(s): Platforms > Drug Delivery > Other Polymers, Platforms > Drug Delivery > Nanoparticles
2014-554 TREHALOSE HYDROGELS FOR STABILIZATION AND DELIVERY OF PROTEINS
Trehalose Hydrogels For Stabilization And Delivery Of ProteinsCase No. 2014-554-0SUMMARYUCLA researchers in the Department of Chemistry and Biochemistry have developed a novel trehalose hydrogel to help stabilize proteins for drug delivery.BACKGROUNDProteins are at the core of biologic drugs and are used to treat a range of disease states including...
Published: 7/17/2025   |   Inventor(s): Heather Maynard
Keywords(s): Drug Delivery, Medical Devices and Materials, Other Polymers, Therapeutics & Vaccines
Category(s): Medical Devices, Platforms > Drug Delivery, Therapeutics, Platforms > Drug Delivery > Other Polymers
2012-340 A Novel Basic Fibroblast Growth Factor Conjugate for Broad Therapeutic Application
A Novel Basic Fibroblast Growth Factor Conjugate for Broad Therapeutic ApplicationSUMMARYUCLA scientists have developed a novel polymer conjugate of basic fibroblast growth factor (bFGF) for use in commercial and possibly clinical applications. This is the first bFGF conjugate to enhance bioactivity and stability under environmental stressors. BACKGROUNDBasic...
Published: 7/17/2025   |   Inventor(s): Heather Maynard, Thi Nguyen
Keywords(s): Catalysts, Dermatology, Other Polymers, Therapeutics & Vaccines
Category(s): Chemical > Synthesis, Therapeutics, Therapeutics > Dermatology, Platforms > Drug Delivery > Other Polymers
1 2